Equillium (EQ) Current Leases (2021 - 2026)

Equillium (EQ) reported Current Leases of $441000.0 for Q1 2026, up 202.05% year-over-year from $146000.0 in Q1 2025, and up 21.49% quarter-over-quarter from $363000.0 in Q4 2025.

Equillium (EQ) Current Leases (2021 - 2026) Analysis & Trends

Equillium (EQ) has 6 years of Current Leases data on file, last reported at $441000.0 in Q1 2026.

  • Current Leases for Q1 2026 came in at $441000.0, up 202.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $441000.0 (up 202.05% YoY), and the FY2025 annual result was $363000.0, up 84.26% from the prior year.
  • Current Leases improved to $441000.0 in Q1 2026 per EQ's latest filing, from $363000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $441000.0 in Q1 2026 and troughed at $146000.0 in Q1 2025.
  • A 5-year average of $352235.3 and a median of $408000.0 in 2022 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2025 and 2026: Current Leases sank 65.57% in 2025, then jumped 202.05% in 2026.
  • A 5-year view of Current Leases shows it stood at $408000.0 in 2022, then grew by 7.84% to $440000.0 in 2023, then sank by 55.23% to $197000.0 in 2024, then jumped by 84.26% to $363000.0 in 2025, then gained by 21.49% to $441000.0 in 2026.
  • Business Quant data shows EQ's Current Leases at $441000.0 in Q1 2026, $363000.0 in Q4 2025, and $272000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 83,991.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 7.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Equillium 293.17 Mn 232.78 Mn - 441,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 441,000.00
Dec 31, 2025 363,000.00
Sep 30, 2025 272,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 146,000.00
Dec 31, 2024 197,000.00
Sep 30, 2024 274,000.00
Jun 30, 2024 350,000.00
Mar 31, 2024 424,000.00
Dec 31, 2023 440,000.00
Sep 30, 2023 428,000.00
Jun 30, 2023 416,000.00
Mar 31, 2023 404,000.00
Dec 31, 2022 408,000.00
Sep 30, 2022 421,000.00
Jun 30, 2022 434,000.00
Mar 31, 2022 420,000.00
Dec 31, 2021 376,000.00